GROUP ONE TRADING, L.P. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is and the CUSIP is 800677956. A total of 4 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,833
-53.7%
36,400
+0.3%
0.00%
Q2 2023$47,190
-60.6%
36,300
-4.7%
0.00%
Q4 2022$119,634
-56.5%
38,100
-32.1%
0.00%
-100.0%
Q3 2022$275,000
+25.6%
56,100
+6.0%
0.00%
Q2 2022$219,000
+711.1%
52,900
+1050.0%
0.00%
Q1 2022$27,000
-82.8%
4,600
-78.0%
0.00%
Q4 2021$157,000
-83.8%
20,900
-80.6%
0.00%
-100.0%
Q3 2021$969,000
+92.6%
107,500
+156.0%
0.00%0.0%
Q2 2021$503,000
-38.6%
42,000
-35.8%
0.00%0.0%
Q1 2021$819,000
-67.7%
65,400
-59.8%
0.00%
-75.0%
Q4 2020$2,537,000
+161.3%
162,600
+58.2%
0.00%
+33.3%
Q3 2020$971,000
-33.2%
102,800
-36.6%
0.00%
-57.1%
Q2 2020$1,453,000
+35.0%
162,200
-4.0%
0.01%
-22.2%
Q1 2020$1,076,000
-14.7%
168,900
+12.0%
0.01%0.0%
Q4 2019$1,262,000
+19.8%
150,800
+29.6%
0.01%0.0%
Q3 2019$1,053,000
-18.8%
116,400
-3.3%
0.01%
-25.0%
Q2 2019$1,297,000
+104.9%
120,400
+81.3%
0.01%
+71.4%
Q1 2019$633,000
-50.8%
66,400
-40.8%
0.01%
-36.4%
Q4 2018$1,287,000
-39.8%
112,100
-11.1%
0.01%
-35.3%
Q3 2018$2,137,000
+100.7%
126,100
+68.1%
0.02%
+88.9%
Q2 2018$1,065,000
-39.4%
75,000
-18.8%
0.01%
-50.0%
Q1 2018$1,756,000
-55.5%
92,400
-61.6%
0.02%
-35.7%
Q4 2017$3,944,000
-14.6%
240,500
-21.9%
0.03%
-33.3%
Q3 2017$4,620,000
+176.0%
308,000
+61.9%
0.04%
+147.1%
Q2 2017$1,674,000
+240.9%
190,200
+101.5%
0.02%
+183.3%
Q1 2017$491,000
+72.3%
94,400
+0.9%
0.01%
+100.0%
Q4 2016$285,000
-52.8%
93,600
-28.3%
0.00%
-57.1%
Q3 2016$604,000
+180.9%
130,500
+251.8%
0.01%
+133.3%
Q2 2016$215,000
-14.7%
37,100
-10.8%
0.00%
-25.0%
Q1 2016$252,000
-66.7%
41,600
-49.8%
0.00%
-55.6%
Q4 2015$757,000
+160.1%
82,900
+60.7%
0.01%
+125.0%
Q3 2015$291,000
-80.9%
51,600
-62.5%
0.00%
-81.0%
Q2 2015$1,525,000
+31.6%
137,500
+86.1%
0.02%
+16.7%
Q1 2015$1,159,000
-50.3%
73,900
-51.8%
0.02%
-48.6%
Q4 2014$2,332,000
+131.6%
153,300
+64.1%
0.04%
+118.8%
Q3 2014$1,007,000
-42.0%
93,400
-17.8%
0.02%
-40.7%
Q2 2014$1,735,000
-26.2%
113,600
-12.7%
0.03%
-32.5%
Q1 2014$2,352,000
+234.6%
130,100
+157.1%
0.04%
+263.6%
Q4 2013$703,000
+96.4%
50,600
+48.0%
0.01%
+57.1%
Q3 2013$358,000
-16.7%
34,200
-37.9%
0.01%
-36.4%
Q2 2013$430,00055,1000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
LUPO SECURITIES, LLC 38$18,0000.14%
GROUP ONE TRADING, L.P. 51,600$291,0000.00%
SIMPLEX TRADING, LLC 35$37,0000.00%
Citadel Advisors 35,700$201,0000.00%
View complete list of SANGAMO THERAPEUTICS INC shareholders